FAKTOR-OPTIONSSCHEIN - GILEAD SCIENCES Stock

Certificat

DE000SQ33CL7

Market Closed - Deutsche Boerse AG 03:35:38 2024-05-31 pm EDT
12.81 EUR -0.08% Intraday chart for FAKTOR-OPTIONSSCHEIN - GILEAD SCIENCES
Current month+1.67%
1 month+1.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 12.81 -0.08%
24-05-30 12.82 -1.31%
24-05-29 12.99 +1.33%
24-05-28 12.82 +4.74%
24-05-27 12.24 -0.08%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:35 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ33CL
ISINDE000SQ33CL7
Date issued 2022-11-10
Strike 82.13 $
Maturity Unlimited
Parity 1 : 1
Emission price 9.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.48
Lowest since issue 7.14
Spread 0.02
Spread %0.16%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
64.27 USD
Average target price
82.7 USD
Spread / Average Target
+28.67%
Consensus